Royalty Report: Medical, Device, Drugs – Collection: 1819

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Medical
  • Device
  • Drugs
  • Pharmaceuticals

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 1819

License Grant
The Company granted an exclusive license to the New Zealand Licensee, a partially owned subsidiary,  for its process and equipment patents and trademark in New Zealand.
License Property
The Patent covers a procedure for ozone decontamination of blood and blood products through the treatment of blood and blood components.
Field of Use
The field of use relates to the medical industry.

IPSCIO Record ID: 1820

License Grant
The Company entered into a Patent Purchase Agreement in 1987 for the rights to an ozone-related invention.  The Patent, which covers a procedure for ozone decontamination of blood and blood products through the treatment of blood and blood components.
License Property
The proprietary scope of the Company is covered under a United States process patent (U.S. Patent No. 4,632,980) entitled, Ozone Decontamination of Blood and Blood Products (the Patent) and a related United States equipment patent (U.S. Patent No. 5,052,382) entitled Approaches for the Control Generation and Administration of Ozone (the Equipment Patent).
Field of Use
The rights granted apply to the healthcare industry.

IPSCIO Record ID: 4928

License Grant
The Company and the NYBC, as co-licensors, entered into a license agreement in which the Licensees became the exclusive worldwide manufacturers and distributors (excluding Japan) for the system of sterile, medical disposable containers developed by the Company and NYBC for the processing of hematopoietic stem cells sourced from PCB.  Licensor grants to Licensee, under the terms and conditions of this Agreement, an exclusive license within the Exclusive Field of Use and the Non-Exclusive Field of Use under the Licensed Patent Rights and Know-How (a) to make, use, sell, or otherwise dispose of the Licensed Products, and (b) to use the methods covered by the Licensed Patent Rights and Know-How for the manufacture, use and sale of Licensed Products. Licensor retains for itself the right to practice for itself, without the right to sublicense distribution, the Licensed Patent Rights and Know How within the Non-Exclusive Field of Use and to use the methods covered by the Licensed Patent Rights and Know-How.
License Property
Licensor has developed know-how and patent rights for plastic disposable bags or containers for the isolation, collection, processing, freezing and infusion of stem cells for use with placental/umbilical cord blood.

Method of Isolation of Stem Cells and Bag Array U.S. #08/349,747
Improved Bag Design and Method of Manufacturing U.S. #08/670,368

Field of Use
Exclusive  Field  of Use@ shall mean the practice of stem cell  isolation and collection from umbilical cord blood, and the freezing, storage, processing and infusion of such stem  cells.
Non-Exclusive Field of Use@ shall mean all other applications of the Licensed Product.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.